What is PulpHEAL™?

PulpHEAL™ employs the use of a patent-pending, 2-part system consisting of a mixture of antibacterial drugs for disinfection of coronal and root canal dentin in order to heal pulpal and periapical lesions.

 • Ciprofloxacin (14%)

Metronidazole (43%)

Clindamycin (43%) replaced Minocyclin due to staining and discoloration of the tooth and gums

*Iodoform  (Triiodomethane 30%)- Optional active ingredient to allow mixture to be radio opaque for x-ray.


Before using PulpHEAL™, please assess the patient for allergies to Ciprofloxacin, Metronidazole, Clindamycin, Iodine, and propylene glycol.  *This has been added to the formula to allow the product to be radio opaque upon x-ray.


Indications for PulpHEAL™

  1. Pulpotomy in primary teeth
  2. Root canal disinfection (and filling) in primary teeth
  3. Intracanal disinfection of mature infected teeth PulpHEAL™

Click the link below to download the PulpHEAL™ order form and PulpHEAL™ mixing instructions.

>>How to order PulpHEAL
>> PulpHEAL Mixing Instructions



MedCara Pharmaceuticals
126 N Main
Conrad, Iowa 50621
Phone: 515.577.6758 |Email
NuCara Pharmacy
1150 5th Street, Suite 140
Coralville, Iowa 52241
Toll Free Ph: 877.268.2272
Ph: 319.354.6006|Fx: 866.354.6381|Email
MedCara Pharmaceuticals NuCara Pharmacy
© 2020 MedCara Pharmaceuticals. All rights reserved. Sitemap|Feedback
The information contained in this website is provided for educational purposes only and is not intended to replace discussions with your healthcare provider. All decisions regarding a patients' treatment must be made with a healthcare provider. PulpVAZ� and PulpHEALTM are available as a compounded medication exclusively from MedCara Pharmaceuticals and dispensed under an exclusive contract by NuCara Pharmacy. PulpVAZ and PulpHEAL as formulations have not been through FDA testing. PulpVAZ and PulpHEAL have been compounded under prescription from a licensed professional and is dispensed under a specific patient name. MedCara Pharmaceuticals and NuCara Pharmacy does not make any claims, overt or implied, of the safety or effectiveness of the PulpVAZ or PulpHEAL compounds. We refer only to references pertaining to peer reviewed medical publications and/or safety studies endorsed by the FDA. In keeping with FDA regulations, MedCara Pharmaceutical�s intentions are to provide pertinent and informative facts and information that will assist a person in making a well informed and educated decision about his/her medical care.
© 2020 MedCara Pharmaceuticals. All Rights Reserved.